FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3103669448> ?p ?o ?g. }

• W3103669448 endingPage "1748" @default.
• W3103669448 startingPage "1743" @default.
• W3103669448 abstract "The purpose of this review is to discuss the current status of local and international efforts undergoing clinical trials aiming at developing a Coronavirus Disease-2019 (COVID-19) vaccine, and to highlight the anticipated challenges of this vaccine globally and in Saudi Arabia.COVID-19 vaccine development efforts started in early January 2020 when Chinese scientists shared the Coronavirus genomic sequence in public domain. Approximately 321 research groups initiated the search for a vaccine, out of which 41 have reached phase I/II trails and 11 reached phase-III clinical trials, including approved vaccines for early to limited use. Out of these projects are two labs in the Kingdom of Saudi Arabia still in early stages of development of a COVID-19 vaccine. Several vaccine attempts are being tested from traditional, attenuated virus methods, to new nucleic acid-based designs. However, no vaccine has yet completed clinical trials and reached public domain.In spite of the challenges faced during previous vaccine trials, researchers have found that Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19 is structurally similar to the (SARS-CoV-1) and the Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), which caused epidemics in 2003 and 2012 respectively. Both SARS strains show identical affinity towards the type-II alveolar pneumocytes angiotensin converting enzyme-2 (ACE-2) receptor binding domains and therefore, similar pathogenicity. The race to develop the vaccine is predominantly for individuals at high risk of developing the infection, i.e. population groups who are most susceptible to experiencing fatal symptoms of the coronavirus. These include patients with comorbidities, above the age of 60 years and people at risk of contracting large viral loads, such as healthcare providers caring for critical admissions in in-patient wards, Intensive Care Units and Emergency Room settings.Many different vaccine strategies are under development throughout different stages of the research timeline; however, it is estimated that none will show favorable results before end of 2020. For any immunization or interventional prevention/therapy system to reach the public and patients at high risk, it needs to undergo multiple phase trials to ensure safety and effectiveness. In this scoping review we aim to map the literature on COVID-19 vaccines and provide recommendations related to gaps in research, applicability and expected challenges for implementation of nationwide vaccination in Saudi Arabia." @default.
• W3103669448 created "2020-11-23" @default.
• W3103669448 creator A5026377057 @default.
• W3103669448 creator A5041382792 @default.
• W3103669448 creator A5074996068 @default.
• W3103669448 date "2020-12-01" @default.
• W3103669448 modified "2023-10-02" @default.
• W3103669448 title "Current COVID-19 vaccine candidates: Implications in the Saudi population" @default.
• W3103669448 cites W2071569701 @default.
• W3103669448 cites W2140338292 @default.
• W3103669448 cites W2328977468 @default.
• W3103669448 cites W2486579689 @default.
• W3103669448 cites W2532586338 @default.
• W3103669448 cites W2763547223 @default.
• W3103669448 cites W2989775291 @default.
• W3103669448 cites W3013521862 @default.
• W3103669448 cites W3013660050 @default.
• W3103669448 cites W3015369767 @default.
• W3103669448 cites W3015371627 @default.
• W3103669448 cites W3016882839 @default.
• W3103669448 cites W3022878099 @default.
• W3103669448 cites W3031136549 @default.
• W3103669448 cites W3034137654 @default.
• W3103669448 cites W3034825141 @default.
• W3103669448 cites W3036454083 @default.
• W3103669448 cites W3037695843 @default.
• W3103669448 cites W3040389884 @default.
• W3103669448 cites W3042383115 @default.
• W3103669448 cites W3042833857 @default.
• W3103669448 cites W3043722389 @default.
• W3103669448 cites W3044311014 @default.
• W3103669448 cites W3048446898 @default.
• W3103669448 cites W3048612433 @default.
• W3103669448 cites W3048775784 @default.
• W3103669448 cites W3081626042 @default.
• W3103669448 doi "https://doi.org/10.1016/j.jsps.2020.10.019" @default.
• W3103669448 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7654289" @default.
• W3103669448 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33199968" @default.
• W3103669448 hasPublicationYear "2020" @default.
• W3103669448 type Work @default.
• W3103669448 sameAs 3103669448 @default.
• W3103669448 citedByCount "17" @default.
• W3103669448 countsByYear W31036694482021 @default.
• W3103669448 countsByYear W31036694482022 @default.
• W3103669448 countsByYear W31036694482023 @default.
• W3103669448 crossrefType "journal-article" @default.
• W3103669448 hasAuthorship W3103669448A5026377057 @default.
• W3103669448 hasAuthorship W3103669448A5041382792 @default.
• W3103669448 hasAuthorship W3103669448A5074996068 @default.
• W3103669448 hasBestOaLocation W31036694481 @default.
• W3103669448 hasConcept C126322002 @default.
• W3103669448 hasConcept C159047783 @default.
• W3103669448 hasConcept C159654299 @default.
• W3103669448 hasConcept C167508917 @default.
• W3103669448 hasConcept C203014093 @default.
• W3103669448 hasConcept C22070199 @default.
• W3103669448 hasConcept C2777648638 @default.
• W3103669448 hasConcept C2778190748 @default.
• W3103669448 hasConcept C2779134260 @default.
• W3103669448 hasConcept C2780801004 @default.
• W3103669448 hasConcept C2908647359 @default.
• W3103669448 hasConcept C3008058167 @default.
• W3103669448 hasConcept C524204448 @default.
• W3103669448 hasConcept C535046627 @default.
• W3103669448 hasConcept C71924100 @default.
• W3103669448 hasConcept C99454951 @default.
• W3103669448 hasConceptScore W3103669448C126322002 @default.
• W3103669448 hasConceptScore W3103669448C159047783 @default.
• W3103669448 hasConceptScore W3103669448C159654299 @default.
• W3103669448 hasConceptScore W3103669448C167508917 @default.
• W3103669448 hasConceptScore W3103669448C203014093 @default.
• W3103669448 hasConceptScore W3103669448C22070199 @default.
• W3103669448 hasConceptScore W3103669448C2777648638 @default.
• W3103669448 hasConceptScore W3103669448C2778190748 @default.
• W3103669448 hasConceptScore W3103669448C2779134260 @default.
• W3103669448 hasConceptScore W3103669448C2780801004 @default.
• W3103669448 hasConceptScore W3103669448C2908647359 @default.
• W3103669448 hasConceptScore W3103669448C3008058167 @default.
• W3103669448 hasConceptScore W3103669448C524204448 @default.
• W3103669448 hasConceptScore W3103669448C535046627 @default.
• W3103669448 hasConceptScore W3103669448C71924100 @default.
• W3103669448 hasConceptScore W3103669448C99454951 @default.
• W3103669448 hasIssue "12" @default.
• W3103669448 hasLocation W31036694481 @default.
• W3103669448 hasLocation W31036694482 @default.
• W3103669448 hasLocation W31036694483 @default.
• W3103669448 hasOpenAccess W3103669448 @default.
• W3103669448 hasPrimaryLocation W31036694481 @default.
• W3103669448 hasRelatedWork W1594151399 @default.
• W3103669448 hasRelatedWork W2004821561 @default.
• W3103669448 hasRelatedWork W2031436792 @default.
• W3103669448 hasRelatedWork W2044069055 @default.
• W3103669448 hasRelatedWork W2078293691 @default.
• W3103669448 hasRelatedWork W2118468715 @default.
• W3103669448 hasRelatedWork W2138868779 @default.
• W3103669448 hasRelatedWork W2155345670 @default.
• W3103669448 hasRelatedWork W2389269289 @default.
• W3103669448 hasRelatedWork W3184379016 @default.

• next